Copertina

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Wolbers, Marcel, Rabuñal, Mar Vázquez, Li, Ke, Rufibach, Kaspar, Bové, Daniel Sabanés
Natura:	Preprint
Pubblicazione:	2024
Soggetti:	Methodology Applications G.3
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Balancing events, not patients, maximizes power of the logrank test: and other insights on unequal randomization in survival trials
di: Yung, Godwin, et al.
Pubblicazione: (2024)

"6 choose 4": A framework to understand and facilitate discussion of strategies for overall survival safety monitoring
di: Yung, Godwin, et al.
Pubblicazione: (2024)

Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints
di: Smith, E. Davies, et al.
Pubblicazione: (2024)

Unified implementation and comparison of Bayesian shrinkage methods for treatment effect estimation in subgroups
di: Wolbers, Marcel, et al.
Pubblicazione: (2026)

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints
di: Owen, Melody, et al.
Pubblicazione: (2025)

Estimating treatment effects with competing intercurrent events in randomized controlled trials
di: Lu, Sizhu, et al.
Pubblicazione: (2025)

Nonparametric estimation of an optimal treatment rule with fused randomized trials and missing effect modifiers
di: Williams, Nicholas, et al.
Pubblicazione: (2025)

Data-driven controlled subgroup selection in clinical trials
di: Müller, Manuel M., et al.
Pubblicazione: (2025)

Subgroup analysis methods for time-to-event outcomes in heterogeneous randomized controlled trials
di: Perrin, Valentine, et al.
Pubblicazione: (2024)

A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders
di: Xu, Xiaoming, et al.
Pubblicazione: (2024)

Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
di: Gao, Chenyin, et al.
Pubblicazione: (2024)

Assurance Methods for designing a clinical trial with a delayed treatment effect
di: Salsbury, James, et al.
Pubblicazione: (2023)

Generalizing conditional average treatment effects from nested randomized trials to all trial-eligible individuals
di: Wen, Lan, et al.
Pubblicazione: (2026)

Selective randomization inference for subgroup effects with continuous biomarkers
di: Gao, Zijun
Pubblicazione: (2025)

The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials
di: Chen, Zhe, et al.
Pubblicazione: (2023)

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and a roadmap for the future of safety analyses in clinical trials
di: Rufibach, Kaspar, et al.
Pubblicazione: (2024)

Rank-based methods for estimating landmark win probability in longitudinal randomized controlled trials with missing data
di: Zou, Guangyong, et al.
Pubblicazione: (2026)

Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
di: Bornkamp, Björn, et al.
Pubblicazione: (2026)

Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
di: Ballerini, Veronica, et al.
Pubblicazione: (2023)

Weighting methods for truncation by death in cluster-randomized trials
di: Isenberg, Dane, et al.
Pubblicazione: (2024)

Bias reduction in g-computation for covariate adjustment in randomized clinical trials
di: Zhang, Xin, et al.
Pubblicazione: (2025)

Extreme value methods for estimating rare events in Utopia
di: André, L. M., et al.
Pubblicazione: (2023)

A robust score test in g-computation for covariate adjustment in randomized clinical trials leveraging different variance estimators via influence functions
di: Zhang, Xin, et al.
Pubblicazione: (2025)

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments
di: Bian, Yuan, et al.
Pubblicazione: (2026)

Comparing estimators of discriminative performance of time-to-event models
di: Jin, Ying, et al.
Pubblicazione: (2024)

A tutorial on conducting sample size and power calculations for detecting treatment effect heterogeneity in cluster randomized trials with linear mixed models
di: Baumann, Mary Ryan, et al.
Pubblicazione: (2025)

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams
di: Morsomme, Raphael, et al.
Pubblicazione: (2025)

Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies
di: Micoli, Chiara, et al.
Pubblicazione: (2024)

Double machine learning to estimate the effects of multiple treatments and their interactions
di: Xiang, Qingyan, et al.
Pubblicazione: (2025)

While-alive regression analysis of composite survival endpoints
di: Fang, Xi, et al.
Pubblicazione: (2025)

A sampling method based on highest density regions: Applications to surrogate models for rare events estimation
di: Minini, Jocelyn, et al.
Pubblicazione: (2025)

Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures
di: Ouyang, Yongdong, et al.
Pubblicazione: (2023)

Consistent Bayesian meta-analysis on subgroup specific effects and interactions
di: Panaro, Renato, et al.
Pubblicazione: (2025)

The R.O.A.D. to clinical trial emulation
di: Bertsimas, Dimitris, et al.
Pubblicazione: (2024)

Treatment bootstrapping: A new approach to quantify uncertainty of average treatment effect estimates
di: Li, Jing
Pubblicazione: (2023)

Estimating time-varying exposure effects through continuous-time modelling in Mendelian randomization
di: Tian, Haodong, et al.
Pubblicazione: (2024)

Targeted learning of heterogeneous treatment effect curves for right censored or left truncated time-to-event data
di: Pryce, Matthew, et al.
Pubblicazione: (2026)

Blinded sample size re-estimation accounting for uncertainty in mid-trial estimation
di: Maeda, Hirotada, et al.
Pubblicazione: (2026)

Causal effects on non-terminal event time with application to antibiotic usage and future resistance
di: Zehavi, Tamir, et al.
Pubblicazione: (2025)

Observing the unobserved confounding through its effects: toward randomized trial-like estimates from real-world survival data
di: Stoumpou, Vasiliki, et al.
Pubblicazione: (2026)